CVS Health Corporation (CVS) Price Targets: What Do They Mean?

0
10
Twitter
Twitter

As of Wednesday close, CVS Health Corporation’s (NYSE:CVS) stock was up $0.55, moving up 0.55 percent to $100.06. The average number of shares traded per day over the past five days has been 5,366,700 shares. 5 times new highs have been achieved over the past 5 days, with a $3.96 gain in that time frame. In the last twenty days, the average volume was 6,862,245, while in the previous 50 days, it was 6,356,620.

Since last month, CVS stock rose 8.50%. Shares of the company fell to $90.76 on 10/25/22, the lowest level in the past month. A 52-week high of $111.25 was reached on 02/08/22 after having rallying from a 52-week low of $86.28. Since the beginning of this year, CVS’s stock price has dropped by -3.01% or -$3.10, and marked a new high 8 times. However, the stock has declined by -10.06% since its 52-week high.


Do You Own These 7 Inflation-Survival Stocks?

Inflation is still near 40-year highs and rising prices are putting a big dent in our wallets. Unless you find out how to protect your portfolio and outpace inflation, you'll keep being at the mercy of economic factors out of your control. Especially since the price of electricity, food, and shelter are creeping up higher than ever. In this special report, I detail 7 stocks to help you survive and thrive in today's market. They're backed by solid companies, positioned to profit during tough economic times, and offer out-sized dividends to help you outpace inflation.

Click here to get your free copy of the report

Sponsored


CVS stock investors should be aware that CVS Health Corporation (CVS) stock had its last reported insider trading activity 113 days ago on Aug 04. Lotvin Alan, the EVP&President-PharmacyServices of the company, disposed of 22,541 shares for $104.00 on Aug 04. It resulted in a $2,344,264 divestment by the insider. Lotvin Alan sold 120,899 shares at an average price of $98.00 on Aug 03. The insider now owns 109,183 shares following the transaction. On Aug 03, EVP/Pres, Health Care Benefits Finke Daniel P sold 9,546 shares at $100.00 apiece. The transaction was valued at $954,600.

Valuation Metrics

Right now, CVS Health Corporation (CVS) has a P/E ratio of about 42.52. The stock’s beta is 0.67. Besides these, the trailing price-to-sales (P/S) ratio of 0.41, the price-to-book (PB) ratio of 1.86, and the price-to-cash flow ratio of 7.70 may also be considered.

The latest dividend of $0.55 per share was paid out, remained unchanged from last year’s $0.55. On Friday December 10 2021, a $0.05 dividend increase was announced.

Financial Health

In the three months ended June 29, CVS Health Corporation’s quick ratio stood at 0.70, while its current ratio was 0.90, showing that the company is not able to pay off its debt. According to company report, the long-term debt-to-equity ratio for the quarter ending June 29 was 0.72, and the total debt-to-equity ratio was 0.74. On the profitability front, the trailing twelve-month gross margin is 39.20% percent. In the year ended June 29, operating margins totaled 2.00%. Based on annual data, CVS earned $116.31 billion in gross profit and brought in $292.11 billion in revenue.

A company’s management is another factor that investors consider when determining the profitability of an investment. In the past year, return on investment (ROI) was 7.80%. Return on equity (ROE) for the past 12 months was 4.30%.

In CVS Health Corporation’s quarter-end financial report for June 29, it reported total debt of $50.85 billion against cash and short-term investments of $2.79 billion. According to the earnings report, the company had a higher net income in the recent quarter than it did in the previous quarter. CVS’s revenue rose 9.07% to $80.64 billion during the quarter, while net income inched up to $81.16 billion. While analysts expected CVS Health Corporation to report $2.17 quarterly earnings, the actual figure was $2.4 per share, beating the consensus estimate by 10.60%. During the quarter, the company generated -$2.88 billion in EBITDA. The liabilities of CVS Health Corporation were 160.2 billion at the end of its most recent quarter ended June 29, and its total debt was $74.17 billion. The value of shareholders’ equity is $1.31 billion.

Technical Picture

This quick technical analysis looks at CVS Health Corporation’s (CVS) price momentum. With a historical volatility rate of 23.76%, the RSI 9-day stood at 62.98% on 23 November.

With respect to its five-day moving average, the current CVS Health Corporation price is up by +4.12% percent or $3.96. At present, CVS shares trade +7.90% above its 20-day simple moving average and +8.14% percent above its 100-day simple moving average. However, the stock is currently trading approximately -0.98% below its SMA50 and -9.72% below its SMA200.

Stochastic coefficient K was 54.96% and Stochastic coefficient D was 45.15%, while ATR was 2.21. Given the Stochastic reading of 66.25% for the 14-day period, the RSI (14) reading has been calculated as 59.37%. As of today, the MACD Oscillator reading stands at 1.57, while the 14-day reading stands at 0.57.

Analyst Ratings

CVS Health Corporation (CVS) has been rated Overweight by analysts. According to 0 brokerage firms, CVS is a sell, and 5 firms recommend it is a Hold. There are 0 analysts who say the stock is underweight. A total of 4 analysts rate CVS Health Corporation stock as buy, with 15 recommending it as overweight.

With a median target price of $118.00, the current consensus forecast for the stock is $98.00 – $130.00. Based on these forecasts, analysts predict CVS Health Corporation (CVS) will achieve an average price target of $116.90.

LEAVE A REPLY

Please enter your comment!
Please enter your name here